PDS Biotechnology Corp·4

Mar 3, 6:47 PM ET

BRAWLEY OTIS W 4

4 · PDS Biotechnology Corp · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-01-12
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    [F1]
    2026-01-12+54,87654,876 total
    Exercise: $0.98Exp: 2036-01-12Common Stock (54,876 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.
Signature
/s/ Spencer Brown, as Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4